- Home
- MYGN vs EXOD Comparison
MYGN vs EXOD Comparison
Compare MYGN & EXOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- EXOD
- Stock Information
- Founded
- MYGN 1991
- EXOD 2015
- Country
- MYGN United States
- EXOD United States
- Employees
- MYGN N/A
- EXOD N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EXOD
- Sector
- MYGN Health Care
- EXOD
- Exchange
- MYGN Nasdaq
- EXOD NYSE
- Market Cap
- MYGN 1.3B
- EXOD 1.4B
- IPO Year
- MYGN 1995
- EXOD N/A
- Fundamental
- Price
- MYGN $8.80
- EXOD $48.46
- Analyst Decision
- MYGN Hold
- EXOD Strong Buy
- Analyst Count
- MYGN 15
- EXOD 3
- Target Price
- MYGN $20.43
- EXOD $59.33
- AVG Volume (30 Days)
- MYGN 875.3K
- EXOD 114.9K
- Earning Date
- MYGN 05-06-2025
- EXOD 05-12-2025
- Dividend Yield
- MYGN N/A
- EXOD N/A
- EPS Growth
- MYGN N/A
- EXOD 758.60
- EPS
- MYGN N/A
- EXOD 3.52
- Revenue
- MYGN $837,600,000.00
- EXOD $116,272,000.00
- Revenue This Year
- MYGN $3.03
- EXOD $10.10
- Revenue Next Year
- MYGN $8.31
- EXOD $26.62
- P/E Ratio
- MYGN N/A
- EXOD $13.76
- Revenue Growth
- MYGN 11.21
- EXOD 106.94
- 52 Week Low
- MYGN $8.53
- EXOD $8.00
- 52 Week High
- MYGN $29.30
- EXOD $117.40
- Technical
- Relative Strength Index (RSI)
- MYGN 27.06
- EXOD N/A
- Support Level
- MYGN $8.53
- EXOD N/A
- Resistance Level
- MYGN $10.30
- EXOD N/A
- Average True Range (ATR)
- MYGN 0.44
- EXOD 0.00
- MACD
- MYGN -0.01
- EXOD 0.00
- Stochastic Oscillator
- MYGN 15.08
- EXOD 0.00
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About EXOD EXODUS MOVEMENT INC
Exodus Movement Inc is a self-custodial platform that connects people with the world of decentralized finance and the power of the blockchain. Available for desktop and mobile, it allows users to secure, manage and exchange cryptocurrencies like Bitcoin, Ethereum. Geographical presence in Europe, United States, the Middle East, and Africa (EMEA); Asia-Pacific (APAC); and Canada and Latin America (Other Americas).